GBR 12909 Study in Cocaine Experienced African American Volunteers - 1
NCT ID: NCT00089687
Last Updated: 2017-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
10 participants
INTERVENTIONAL
2004-04-30
2005-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
NCT00051896
Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1
NCT00100113
Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals
NCT00218049
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
NCT00032916
Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
NCT00067535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GBR 12909
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must understand the study procedures and provide written informed consent.
* Must meet DSM-4 criteria for abuse or dependence on cocaine.
* Must be non-treatment seeking at the time of the study.
Exclusion Criteria
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louis Cantilena, M.D.
Role: PRINCIPAL_INVESTIGATOR
Uniformed Services University of Health Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uniformed Services University of Health Science
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-CPU-0005-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.